ProShare Advisors’s KALA BIO KALA Stock Holding History

ProShare Advisors’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4	Closed	-$12K	–	2254
2021 Q4	$12K	Sell	4 -4	-50%	-$18.6K	﹤0.01%	2338
2021 Q3	$53K	Sell	8 -2	-20%	-$17.3K	﹤0.01%	1959
2021 Q2	$128K	Buy	10 +2	+25%	+$31.4K	﹤0.01%	2250
2021 Q1	$129K	Buy	8 +1	+14%	+$19.5K	﹤0.01%	2130
2020 Q4	$118K	Buy	+7	New	+$132K	﹤0.01%	1965
2019 Q4	–	Sell	-5	Closed	-$44K	–	1794
2019 Q3	$44K	Hold	5	–	–	﹤0.01%	1611
2019 Q2	$74K	Hold	5	–	–	﹤0.01%	1556
2019 Q1	$109K	Hold	5	–	–	﹤0.01%	1564
2018 Q4	$64K	Hold	5	–	–	﹤0.01%	1516
2018 Q3	$113K	Hold	5	–	–	﹤0.01%	1669
2018 Q2	$163K	Hold	5	–	–	﹤0.01%	1655
2018 Q1	$208K	Sell	5 -1	-17%	-$38K	﹤0.01%	1527
2017 Q4	$264K	Buy	+6	New	+$281K	﹤0.01%	1474

Other funds holding KALA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

VAFP

Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return

Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ProShare Advisors's KALA Position: Q1 2022 in Review

ProShare Advisors sold out of KALA BIO (KALA) in Q1 2022, closing a stake of 4 shares — an estimated $12K sold.

ProShare Advisors first reported a position in KALA in Q4 2017 and held it in 13 quarters. The position peaked at $264K in Q4 2017. 82 funds tracked by Wall St. Rank hold KALA as of Q1 2022.

ProShare Advisors reported no remaining KALA BIO position as of Q1 2022 after selling out during the quarter.
ProShare Advisors sold 4 KALA BIO shares in Q1 2022, an estimated $12K.
ProShare Advisors first reported a position in KALA BIO in Q4 2017 and held it in 13 quarters.
ProShare Advisors's KALA BIO position peaked at $264K in Q4 2017.
82 funds tracked by Wall St. Rank held KALA BIO as of Q1 2022.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.